Mie, Japan

Hitoshi Ito

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tsu, Mie, JP (2000)
  • Mie, JP (2016)

Company Filing History:


Years Active: 2000-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hitoshi Ito: Innovator in Mycology and Medical Applications

Introduction

Hitoshi Ito is a notable inventor based in Mie, Japan. He has made significant contributions to the field of mycology and its applications in medicine. With a focus on innovative methods for treating serious health conditions, Ito has been awarded 2 patents for his groundbreaking work.

Latest Patents

Hitoshi Ito's latest patents include a method of inhibiting angiogenesis. This method involves applying a specific protein polysaccharide derived from a (1→6)-β-D-glucan obtained from the residue of extraction of crushed dried fruiting bodies of Himematsutake using an 80% ethanol aqueous solution and hot water at 100 degrees Celsius. Another significant patent is for oral drugs designed for treating AIDS patients. These drugs contain water-soluble mixed components derived from cultured mycelia or a culture filtrate solution of Himematsutake (Agaricus blazei).

Career Highlights

Throughout his career, Hitoshi Ito has worked with various research institutions, including the Iwade Research Institute of Mycology Co., Ltd. His innovative approaches have positioned him as a key figure in the development of medical treatments based on fungal components.

Collaborations

Hitoshi Ito has collaborated with several professionals in his field, including Toshimitsu Sumiya and Hiroko Itoh. These collaborations have further enhanced his research and development efforts.

Conclusion

Hitoshi Ito's contributions to mycology and medical applications demonstrate his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of the potential of natural substances in treating serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…